HEINZ NIXDORF RECALL STUDIE PDF
Heinz Nixdorf Recall Study. Cardiovascular diseases are still the most frequent cause of death in the industrialized countries. Unfortunately, myocardial. Initiated in , the Heinz Nixdorf Recall Study involved 4, European participants. The results proved, for the first time, the connection. Request PDF on ResearchGate | Die Heinz Nixdorf Recall Studie | The Heinz Nixdorf Recall Study is a population-based study that aims to improve the.
|Published (Last):||21 March 2009|
|PDF File Size:||6.74 Mb|
|ePub File Size:||15.48 Mb|
|Price:||Free* [*Free Regsitration Required]|
This article discusses the present findings of the Heinz Nixdorf Recall Study with respect to the current literature, risk stratification algorithms, and current European guidelines for risk prediction.
Non-contrast-enhanced computed tomography CT imaging of the heart enables noninvasive quantification of coronary artery calcification CACa surrogate marker of the atherosclerotic burden in the coronary artery tree. The study was initiated in the late s and enrolled a total of 4, participants aged years between December and August The Heinz Nixdorf Recall Study will significantly extend our knowledge about new modalities in the prediction of cardiac events.
[The Heinz Nixdorf Recall study].
Primary endpoints are myocardial infarction and sudden cardiac death. Extending the original aims of the study, serial CAC measurements will stuide the characterization of the natural history of CAC dynamics, the identification of its determinants and an understanding of the impact of CAC progression on the primary endpoints.
Multiple studies have underlined reacll ability of CAC score for individual risk stratification and, accordingly, the American Heart Association recommended cardiac CT for risk assessment in individuals with an intermediate risk of cardiovascular events as measured by Framingham Risk Score. One focus of the study is the evaluation of the quantification of subclinical coronary artery calcifications coronary artery calcification, CAC as a prognostic factor in predicting cardiac events.
According to Heinz Nixdorf Recall findings, CAC can be used for reclassification, especially in those in the intermediate-risk group, to advise on lifestyle changes for the reclassified low-risk category, or to implement intensive treatments for the reclassified high-risk individuals. However, limitations in transcribing risk stratification algorithms based on American cohort studies into European populations have been recalll in the past.
The Heinz Nixdorf Recall HNR study is a population-based cohort study that investigated the ability of CAC scoring in risk prediction for major cardiovascular events above and beyond traditional cardiovascular risk factors. Currently, the year follow-up is under way and is estimated to be finished in July The Heinz Nixdorf Recall Study is a population-based study that aims to improve the prediction of cardiovascular events by integrating new imaging and non-imaging modalities in risk assessment.
Moreover, data on implications for reclassification into higher- or lower-risk groups based on CAC scores were lacking. A 5-year follow-up examination took place between and